Atrial Fibrillation and Antithrombosis Forum-3 心房颤动与抗凝治疗
|
13:30-15:30
|
|---|
| 主席 Chairmen | 华伟 Wei HUA, 项美香 Meixiang XIANG, 胡晓晟 Xiaosheng HU, 刘少稳 Shaowen LIU | ||
| 讨论嘉宾 Discussants | 杨剑 Jian YANG, 陈建明 Jianming CHEN, 曹江 Jiang CAO, 袁红 Hong YUAN | ||
|
13:30-13:50 |
主席开场 Opening Remarks |
||
|
13:50-14:10 |
《中国心房颤动管理指南（2025）》更新要点及解读 Update Points and Interpretation of the “Chinese Guidelines for the Management of Atrial Fibrillation (2025)” |
蒋晨阳 Chenyang JIANG | |
|
14:10-14:30 |
老年房颤伴共病复杂临床，探寻老年科DOACs抗凝优选 Complex Clinical Situation of Elderly Atrial Fibrillation with Comorbidities: Exploring the Optimal DOACs Anticoagulation in Geriatrics |
王云帆 Yunfan WANG | |
|
14:30-14:50 |
ESC2025 房颤抗凝前沿：NOAC个体化应用的新增优势证据与启示 Frontier of Atrial Fibrillation Anticoagulation at ESC2025: New Advantageous Evidence and Enlightenment for Individualized Application of NOACs |
牛红霞 Hongxia NIU | |
|
14:50-15:10 |
房颤合并冠心病DOAC单药抗凝最新力证 Latest Evidence for DOAC Monotherapy Anticoagulation in Atrial Fibrillation Complicated with Coronary Heart Disease |
肖方毅 Fangyi XIAO | |
|
15:10-15:30 |
讨论 Discussion |
||
Intravascular Imaging Forum-2
|
15:30-18:00
|
|---|
| 主持 Moderators | 韩战营 Zhanying HAN, 金基永 Jiyong JIN, 潘宏伟 Hongwei PAN, 薛强 Qiang XUE | ||
|
15:30-15:50 |
易损高危斑块IVUS智能辅助识别项目方案研讨 Symposium on the Project Solution for AI-Aided Detection of Vulnerable and High-Risk Plaques by IVUS |
刘炳辰 Bingchen LIU | |
|
15:50-16:10 |
人工智能在腔内影像中的应用 Application of Artificial Intelligence in Intravascular Imaging |
魏渠成 Qucheng WEI | |
|
16:10-16:30 |
智慧赋能：国产多构型腔内影像技术新突破 AI-Enabled: Novel Breakthroughs in Domestic Multi-Configuration Intravascular Imaging Technology |
肖明阳 Mingyang XIAO | |
|
16:30-16:50 |
宽频心声：国产新型腔内影像导管技术新探 Ultra-Wideband: Exploring Novel Domestic Intravascular Imaging Catheter Technology |
王齐明 Qiming WANG | |
|
16:50-17:10 |
智影融合：腔内影像人工智能研究新进展 AI-Imaging Integration: Recent Advances in Intravascular Imaging AI Research |
曹锡华 Xihua CAO | |
|
四大慢病国家科技重大专项启动会 |
||||
|---|---|---|---|---|
|
17:10-17:15 |
致辞 Opening Remarks |
定 待 | ||
|
17:15-17:20 |
项目负责人研究方案介绍 Introduction to the Principal Investigator’s Research Proposal |
刘炳辰 Bingchen LIU | ||
|
17:20-17:30 |
研究项目汇报-子课题1 Research Project Report - Sub-research Topic 1 |
郭启强 Qiqiang GUO | ||
|
17:30-17:40 |
研究项目汇报-子课题2 Research Project Report - Sub-research Topic 2 |
杨俊杰 Junjie YANG | ||
|
17:40-17:50 |
研究项目汇报-子课题3 Research Project Report - Sub-research Topic 3 |
朱云鹏 Yunpeng ZHU | ||
|
17:50-18:00 |
研究项目汇报-子课题4 Research Project Report - Sub-research Topic 4 |
刘炳辰 Bingchen LIU | ||
Pulsed-Field Ablation Forum-1 Carto Innovation
|
08:00-10:00
|
|---|
| 主席 Chairmen | 林加锋 Jiafeng LIN, 樊友启 Youqi FAN | ||
| 主持 Moderators | 潘永康 Yongkang PAN, 郑武扬 Wuyang ZHENG, 夏淑东 Shudong XIA, 葛卫力 Weili GE, 王亚萍 Yaping WANG | ||
|
08:00-08:20 |
PFA的现在与未来 Present and Future of PFA |
刘少稳 Shaowen LIU | |
|
08:20-08:40 |
绿色PFA手术流程和技术要点 Green PFA Workflow and Technical Key Points |
蒋晨阳 Chenyang JIANG | |
|
08:40-09:00 |
PFA房颤消融临床实践与再认识 PFA Ablation for Atrial FibrillationClinical Practice and Reappraisal |
李强 Qiang LI | |
|
09:00-09:20 |
房颤脉冲消融并发症的预防与处理 Prevention and Management of Complications in PFA for Atrial Fibrillation |
常栋 Dong CHANG | |
|
09:20-09:40 |
高效三维脉冲消融流程和价值分享 3D Mapping in Pulsed Field Ablation — Efficient Workflow and Value Insights |
张必祺 Biqi ZHANG | |
|
09:40-10:00 |
脉冲场在持续性房颤中的应用 The Application of PFA in Persistent Atrial Fibrillation |
肖方毅 Fangyi XIAO | |
Cardio-Renal Forum-4
|
10:00-12:00
|
|---|
| 主席 Chairmen | 蒋峻 Jun JIANG, 毛威 Wei MAO | ||
| 主持 Moderators | 叶红华 Honghua YE, 吴连拼 Lianpin WU, 张邢炜 Xingwei ZHANG, 胡惠林 Huilin HU | ||
| 讨论嘉宾 Discussants | 何文明 Wenming HE, 米亚非 Yafei MI, 姚俊龙 Junlong YAO, 曹建成 Jiancheng CAO | ||
|
10:00-10:05 |
开场 Opening Remarks |
蒋峻 Jun JIANG | |
|
10:05-10:25 |
2025ESC/EAS血脂管理指南更新要点解读 Key Updates in the 2025 ESC/EAS Guidelines for Lipid Management |
何奔 Ben HE | |
|
10:25-10:45 |
回顾源头，筑就经典——从斑块认知变迁看他汀在逆转斑块中的基石地位 Revisiting the Origin, Building a Classic: The Cornerstone Role of Statins in Plaque Regression from the Perspective of Evolving Plaque Understanding |
陈桢玥 Zhenyue CHEN | |
|
10:45-11:05 |
CKM管理，没“他”不行——论他汀在心血管代谢疾病防治中的基石地位 CKM Management: The Indispensable Role of Statins in Preventing and Managing Cardiometabolic Diseases |
彭道泉 Daoquan PENG | |
|
11:05-11:25 |
他汀护心，兼顾安全——他汀降脂治疗中如何权衡肝脏风险 Statin Cardioprotection with Safety Considerations: Balancing Liver Risks in Lipid-Lowering Therapy |
茅益民 Yimin MAO | |
|
11:25-11:45 |
PCSK9i应答不良病例一例：对于以他汀为基础的标准化降脂方案的探讨 A Case of Poor Response to PCSK9 Inhibitors: Discussion on Standardized Statin-Based Lipid-Lowering Strategies |
苏立杰 Lijie SU | |
|
11:45-12:00 |
讨论&总结 Discussion & Remarks |
||
Pulsed-Field Ablation Forum-2
|
13:30-15:30
|
|---|
| 主持 Moderators | 夏云龙 Yunlong XIA, 张必祺 Biqi ZHANG, 郁一波 Yibo YU | ||
|
13:30-13:50 |
PFA在持续性房颤中的应用策略 Application Strategy of PFA in Persistent Atrial Fibrillation |
徐娟 Juan XU | |
|
13:50-14:10 |
PFA围手术期并发症预防策略及一站式单中心经验分享 Perioperative Complication Prevention Strategy of PFA and One-Stop Single-Center Experience Sharing |
燕翼 Yi YAN | |
|
14:10-14:30 |
影像融合技术与PFA手术精准化 Image Fusion Technology and Precision of PFA Surgery |
樊友启 Youqi FAN | |
|
14:30-14:50 |
三维环形导管PFA消融的初步应用体会 Initial Clinical Experience with 3D-Guided Circular Catheter for Pulsed-Field Ablation |
唐恺 Kai TANG | |
|
14:50-15:10 |
脉冲消融中精准贴靠的有效性及安全性文献解析 Analysis of Efficacy and Safety of Precise Catheter-Tissue Contact in Pulsed-field Ablation: A Literature Review |
杨剑 Jian YANG | |
|
15:10-15:30 |
讨论 Discussion |
||
Anticoagulation Symposium
|
15:30-17:30
|
|---|
| 主持 Moderators | 王利宏 Lihong WANG, 蒋晨阳 Chenyang JIANG, 陈治奎 Zhikui CHEN, 李杨玲 Yangling LI, 方崇峰 Chongfeng FANG | ||
|
15:30-15:50 |
全球血栓管理循证与实践新进展 Global New Advances in Evidence-Based Practice of Thrombosis Management |
刘少稳 Shaowen LIU | |
|
15:50-16:10 |
房颤导管消融围术期的抗凝优化管理策略 Optimized Anticoagulation Management in the Perioperative Period of Atrial Fibrillation Catheter Ablation |
夏淑东 Shudong XIA | |
|
16:10-16:30 |
浙江抗凝药师管理联盟分享 Sharing of Zhejiang Anticoagulant Pharmacist Management Alliance |
徐慧敏 Huimin XU | |
|
16:30-16:50 |
房颤合并冠心病患者优选的抗栓方案 The Preferred Antithrombotic Regimen for Patients with Atrial Fibrillation Combined with Coronary Heart Disease |
潘轶斌 Yibin PAN | |
|
16:50-17:10 |
深度解读中国房颤管理指南（2025) In-Depth Interpretation of the Chinese Guidelines for the Management of Atrial Fibrillation (2025) |
陈晓敏 Xiaomin CHEN | |
|
17:10-17:30 |
讨论 Discussion |
||
Pan-Vascular Health Management Forum-1
|
08:00-09:50
|
|---|
| 主持 Moderators | 郭谊 Yi GUO, 黄童 Tong HUANG, 葛承辉 Chenghui GE, 周添添 Tiantian ZHOU, 陈北琛 Beichen CHEN | ||
|
08:00-08:05 |
开场致辞 Opening Remarks |
宋震亚 Zhenya SONG | |
|
08:05-08:25 |
亚洲国家心脏骤停患者的共病流行状况与影响 Comorbidity Prevalence and Impact in Patients with Cardiac Arrest in Asian Countries |
洋 赵 | |
|
08:25-08:50 |
人工智能和心脑血管病管理 Artificial Intelligence and Cardio-Cerebrovascular Disease Management |
褚熙 Xi CHU | |
|
08:50-09:15 |
健康生活方式促进心血管健康 Healthy Lifestyle Promotes Cardiovascular Health |
胡荣 Rong HU | |
|
09:15-09:40 |
慢病管理演变与生活方式引领 Evolution of Chronic Disease Management and Lifestyle Guidance |
蒋天武 Tianwu JIANG | |
|
09:40-09:50 |
提问与讨论 Q&A and Discussion |
||
Pan-Vascular Health Management Forum-2
|
09:50-12:00
|
|---|
| 主持 Moderators | 汤红玫 Hongmei TANG, 陈曦 Xi CHEN, 李佳选 Jiaxuan LI | ||
|
09:50-10:15 |
心血管风险人群的全科管理 General Practice Management of Populations at Cardiovascular Risk |
江孙芳 Sunfang JIANG | |
|
10:15-10:40 |
心血管代谢性疾病的全程管理 Whole-Course Management of Cardiometabolic Diseases |
王留义 Liuyi WANG | |
|
10:40-11:05 |
应用行为科学赋能泛血管健康管理 Empowering Pan-Vascular Health Management with Behavioral Science |
张宁 Ning ZHANG | |
|
11:05-11:25 |
高血压治疗的依从性管理 Compliance Management of Hypertension Treatment |
廖晓阳 Xiaoyang LIAO | |
|
11:25-11:45 |
泛血管健康管理与抗炎治疗 Pan-Vascular Health Management and Anti-Inflammatory Treatment |
郭谊 Yi GUO | |
|
11:45-12:00 |
提问与讨论 Q&A and Discussion |
||